Aug. 12, 1927, New York.
BA in Social Sciences, City College of New York, 1949; LLB, Yale Law School, 1952.
CEO, Forest Labs, since 1977; chairman since 1998.
BEST BUSINESS DECISION
Licensed a popular European antidepressant from H. Lundbeck in 1996. The drug, sold in the U.S. as Celexa, rang up sales of $980 million last year.
HIS PRIMARY IMPETUS
When his son Andrew was debilitated by depression, Solomon researched treatments and found that Lundbeck's drug wasn't available in the U.S.
At Celexa's launch, Solomon read from the draft of Andrew's book about depression.
THOUGHTS ON DEPRESSION
"It makes you deal with life's problems: love and unrequited love. It makes you deeper."
Widowed; two sons, Andrew and David.